Status:
COMPLETED
The Impact of Virtual Reality and Kaleidoscope in Children During Vaccination
Lead Sponsor:
Ege University
Conditions:
Pain
Pediatric Patient
Eligibility:
All Genders
48-48 years
Phase:
NA
Brief Summary
This study was designed to examine the effects of using virtual reality and kaleidoscope during routine vaccination in children aged 48 months on pain, fear, and anxiety. Children aged 48 months who w...
Eligibility Criteria
Inclusion
- being 48 months
- being conscious (with the ability to communicate).
Exclusion
- Having a physical and psychological condition that prevents them from wearing glasses to view VR;
- Having a visual problem
- Having mental or physical disabilities
- Taking any analgesics, sedatives, or anticonvulsants in the past 24 hours
- Having chronic or life-threatening disease
- Refusing the VR or kaleidoscope intervention during vaccine injection.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06112600
Start Date
September 15 2021
End Date
June 30 2023
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University
Izmir, Bornova, Turkey (Türkiye), 35040